ResMed: Fear-Driven Selloff Creates A Compelling Margin Of Safety Entry Point (NYSE:RMD)

ResMed (RMD) is characterized by a durable business model built on recurring revenue streams and brand resilience. The article suggests recent market weakness has created a margin of safety entry opportunity, implying valuation compression amid sector or broader equity volatility. This positioning reflects a contrarian stance where temporary selling pressure presents a tactical buying window for long-term holders.

The razor-and-blade model referenced indicates RMD's revenue derives from both capital equipment sales and consumable refills, generating predictable, high-margin recurring revenue. Inexpensive consumable costs and user experience lock-in create structural competitive advantages that support pricing power and customer retention, reducing churn risk relative to peers. This architecture typically sustains valuations during downturns.

Fear-driven selloffs often disconnect valuation from fundamental stability, particularly in healthcare where demand remains relatively inelastic. RMD's resilience through prior cycles, combined with its installed base and ecosystem stickiness, suggests current weakness may be cyclical rather than structural, warranting selective accumulation at depressed multiples for patience-rewarded investors.

Sector implication: Health Care defensiveness strengthens during risk-off environments. RMD's combination of recurring revenue, pricing power, and high barriers to entry positions it as a relative outperformer in prolonged corrections, supporting the thesis that fear-driven dislocations in quality healthcare names often prove temporary.